Elie J. Ritch
Vancouver, BC, Canada
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 16 publications
Randomized Phase II Study of Durvalumab with or without Tremelimumab in Patients with Metastatic Castration-Resistant Prostate Cancer.
Journal: Clinical cancer research : an official journal of the American Association for Cancer Research
Published: May 23, 2024
A generalizable machine learning framework for classifying DNA repair defects using ctDNA exomes.
Journal: NPJ precision oncology
Published: November 12, 2022
A genome-wide CRISPR screen maps endogenous regulators of PPARG gene expression in bladder cancer.
Journal: iScience
Published: October 06, 2022
Genomic Features of Lung-Recurrent Hormone-Sensitive Prostate Cancer.
Journal: JCO precision oncology
Published: May 04, 2022
Deep whole-genome ctDNA chronology of treatment-resistant prostate cancer.
Journal: Nature
Published: November 13, 2021
Somatic Features of Response and Relapse in Non-muscle-invasive Bladder Cancer Treated with Bacillus Calmette-Guérin Immunotherapy.
Journal: European urology oncology
Published: September 02, 2021
BRCA2, ATM, and CDK12 Defects Differentially Shape Prostate Tumor Driver Genomics and Clinical Aggression.
Journal: Clinical cancer research : an official journal of the American Association for Cancer Research
Published: September 18, 2020
Activating AKT1 and PIK3CA Mutations in Metastatic Castration-Resistant Prostate Cancer.
Journal: European urology
Published: January 20, 2020
Identification of Hypermutation and Defective Mismatch Repair in ctDNA from Metastatic Prostate Cancer.
Journal: Clinical cancer research : an official journal of the American Association for Cancer Research
Published: May 17, 2019
Circulating Tumor DNA Abundance and Potential Utility in De Novo Metastatic Prostate Cancer.
Journal: European urology
Published: September 21, 2018
Last Updated: 09/26/2026